Kisqali
Latest Kisqali news
1 article
Companies
Kisqali Reduces Risk of Death by 19.1% in Early Breast Cancer
Kisqali from Novartis reduces the risk of death by 19.1% in high-risk early HR+/HER2- breast cancer compared to endocrine therapy alone, according to the NATALEE trial.